Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5)

Philip M. Carpenter, Anh V. Dao, Zahida S. Arain, Michelle K. Chang, Hoa P. Nguyen, Shehla Arain, Jessica Wang-Rodriguez, Soon Young Kwon, Sharon P. Wilczynski

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Host interactions with tumor cells contribute to tumor progression by several means. This study was done to determine whether mammary epithelium could interact with breast carcinoma by producing substances capable of inducing motility in the cancer cells. Conditioned medium of immortalized 184A1 mammary epithelium collected in serum-free conditions induced dose-dependent motility in the MCF-7 breast carcinoma cell line by both a semiquantitative scattering assay and a Boyden chamber assay. Purification of the motility factor revealed that it was laminin 332 (formerly laminin 5) by mass spectroscopy. A Western blot of the 184A1 conditioned medium using a polyclonal antibody confirmed the presence of laminin 332 in the conditioned medium. Blockage of the motility with antibodies to the laminin 332 and its receptor components, α3 and β1 integrins, provided further evidence that tumor cell motility was caused by the laminin 332 in the conditioned medium. Invasion of MCF-7, BT-20, and MDA-MB-435S was induced by purified laminin 332 and 184A1 conditioned medium and blocked by an anti-α3 integrin antibody. Staining of carcinoma in situ from breast cancer specimens revealed that laminin 332 in the myoepithelium adjacent to the preinvasive cells provided a source of laminin 332 that could potentially encourage the earliest steps of stromal invasion. In metaplastic breast carcinomas, the presence of laminin 332-producing cells coexpressing α3 integrin and the greater metastatic potential of tumors with higher laminin 332 levels suggest that laminin 332 expression is associated with aggressive features in these human breast cancers.

Original languageEnglish
Pages (from-to)462-475
Number of pages14
JournalMolecular Cancer Research
Volume7
Issue number4
DOIs
Publication statusPublished - 2009 Apr 1

Fingerprint

Breast
Breast Neoplasms
Conditioned Culture Medium
Integrins
Neoplasms
Antibodies
kalinin
Epithelium
Carcinoma in Situ
Cell Movement
Mass Spectrometry
Western Blotting
Staining and Labeling
Cell Line
Serum

ASJC Scopus subject areas

  • Molecular Biology
  • Oncology
  • Cancer Research

Cite this

Carpenter, P. M., Dao, A. V., Arain, Z. S., Chang, M. K., Nguyen, H. P., Arain, S., ... Wilczynski, S. P. (2009). Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). Molecular Cancer Research, 7(4), 462-475. https://doi.org/10.1158/1541-7786.MCR-08-0148

Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). / Carpenter, Philip M.; Dao, Anh V.; Arain, Zahida S.; Chang, Michelle K.; Nguyen, Hoa P.; Arain, Shehla; Wang-Rodriguez, Jessica; Kwon, Soon Young; Wilczynski, Sharon P.

In: Molecular Cancer Research, Vol. 7, No. 4, 01.04.2009, p. 462-475.

Research output: Contribution to journalArticle

Carpenter, PM, Dao, AV, Arain, ZS, Chang, MK, Nguyen, HP, Arain, S, Wang-Rodriguez, J, Kwon, SY & Wilczynski, SP 2009, 'Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5)', Molecular Cancer Research, vol. 7, no. 4, pp. 462-475. https://doi.org/10.1158/1541-7786.MCR-08-0148
Carpenter, Philip M. ; Dao, Anh V. ; Arain, Zahida S. ; Chang, Michelle K. ; Nguyen, Hoa P. ; Arain, Shehla ; Wang-Rodriguez, Jessica ; Kwon, Soon Young ; Wilczynski, Sharon P. / Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). In: Molecular Cancer Research. 2009 ; Vol. 7, No. 4. pp. 462-475.
@article{90588829fd8c483f99e89d67fbc178c5,
title = "Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5)",
abstract = "Host interactions with tumor cells contribute to tumor progression by several means. This study was done to determine whether mammary epithelium could interact with breast carcinoma by producing substances capable of inducing motility in the cancer cells. Conditioned medium of immortalized 184A1 mammary epithelium collected in serum-free conditions induced dose-dependent motility in the MCF-7 breast carcinoma cell line by both a semiquantitative scattering assay and a Boyden chamber assay. Purification of the motility factor revealed that it was laminin 332 (formerly laminin 5) by mass spectroscopy. A Western blot of the 184A1 conditioned medium using a polyclonal antibody confirmed the presence of laminin 332 in the conditioned medium. Blockage of the motility with antibodies to the laminin 332 and its receptor components, α3 and β1 integrins, provided further evidence that tumor cell motility was caused by the laminin 332 in the conditioned medium. Invasion of MCF-7, BT-20, and MDA-MB-435S was induced by purified laminin 332 and 184A1 conditioned medium and blocked by an anti-α3 integrin antibody. Staining of carcinoma in situ from breast cancer specimens revealed that laminin 332 in the myoepithelium adjacent to the preinvasive cells provided a source of laminin 332 that could potentially encourage the earliest steps of stromal invasion. In metaplastic breast carcinomas, the presence of laminin 332-producing cells coexpressing α3 integrin and the greater metastatic potential of tumors with higher laminin 332 levels suggest that laminin 332 expression is associated with aggressive features in these human breast cancers.",
author = "Carpenter, {Philip M.} and Dao, {Anh V.} and Arain, {Zahida S.} and Chang, {Michelle K.} and Nguyen, {Hoa P.} and Shehla Arain and Jessica Wang-Rodriguez and Kwon, {Soon Young} and Wilczynski, {Sharon P.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1158/1541-7786.MCR-08-0148",
language = "English",
volume = "7",
pages = "462--475",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5)

AU - Carpenter, Philip M.

AU - Dao, Anh V.

AU - Arain, Zahida S.

AU - Chang, Michelle K.

AU - Nguyen, Hoa P.

AU - Arain, Shehla

AU - Wang-Rodriguez, Jessica

AU - Kwon, Soon Young

AU - Wilczynski, Sharon P.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Host interactions with tumor cells contribute to tumor progression by several means. This study was done to determine whether mammary epithelium could interact with breast carcinoma by producing substances capable of inducing motility in the cancer cells. Conditioned medium of immortalized 184A1 mammary epithelium collected in serum-free conditions induced dose-dependent motility in the MCF-7 breast carcinoma cell line by both a semiquantitative scattering assay and a Boyden chamber assay. Purification of the motility factor revealed that it was laminin 332 (formerly laminin 5) by mass spectroscopy. A Western blot of the 184A1 conditioned medium using a polyclonal antibody confirmed the presence of laminin 332 in the conditioned medium. Blockage of the motility with antibodies to the laminin 332 and its receptor components, α3 and β1 integrins, provided further evidence that tumor cell motility was caused by the laminin 332 in the conditioned medium. Invasion of MCF-7, BT-20, and MDA-MB-435S was induced by purified laminin 332 and 184A1 conditioned medium and blocked by an anti-α3 integrin antibody. Staining of carcinoma in situ from breast cancer specimens revealed that laminin 332 in the myoepithelium adjacent to the preinvasive cells provided a source of laminin 332 that could potentially encourage the earliest steps of stromal invasion. In metaplastic breast carcinomas, the presence of laminin 332-producing cells coexpressing α3 integrin and the greater metastatic potential of tumors with higher laminin 332 levels suggest that laminin 332 expression is associated with aggressive features in these human breast cancers.

AB - Host interactions with tumor cells contribute to tumor progression by several means. This study was done to determine whether mammary epithelium could interact with breast carcinoma by producing substances capable of inducing motility in the cancer cells. Conditioned medium of immortalized 184A1 mammary epithelium collected in serum-free conditions induced dose-dependent motility in the MCF-7 breast carcinoma cell line by both a semiquantitative scattering assay and a Boyden chamber assay. Purification of the motility factor revealed that it was laminin 332 (formerly laminin 5) by mass spectroscopy. A Western blot of the 184A1 conditioned medium using a polyclonal antibody confirmed the presence of laminin 332 in the conditioned medium. Blockage of the motility with antibodies to the laminin 332 and its receptor components, α3 and β1 integrins, provided further evidence that tumor cell motility was caused by the laminin 332 in the conditioned medium. Invasion of MCF-7, BT-20, and MDA-MB-435S was induced by purified laminin 332 and 184A1 conditioned medium and blocked by an anti-α3 integrin antibody. Staining of carcinoma in situ from breast cancer specimens revealed that laminin 332 in the myoepithelium adjacent to the preinvasive cells provided a source of laminin 332 that could potentially encourage the earliest steps of stromal invasion. In metaplastic breast carcinomas, the presence of laminin 332-producing cells coexpressing α3 integrin and the greater metastatic potential of tumors with higher laminin 332 levels suggest that laminin 332 expression is associated with aggressive features in these human breast cancers.

UR - http://www.scopus.com/inward/record.url?scp=65549119715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549119715&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-08-0148

DO - 10.1158/1541-7786.MCR-08-0148

M3 - Article

VL - 7

SP - 462

EP - 475

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 4

ER -